331 – 340 of 540
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours
2010) 35th European-Society-for-Medical-Oncology (ESMO) Congress In Annals of Oncology 21(Suppl. 8). p.177-178(
- Contribution to journal › Published meeting abstract
-
Mark
Extracorporeal techniques for improving radioimmunotherapy of disseminated malignant tumors
2010)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro
(
- Contribution to journal › Article
- 2009
-
Mark
Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study
(
- Contribution to journal › Article
-
Mark
No positive effect of postmastectomy radiotherapy on mortality at 20 years in pre menopausal women with stage II breast cancer also treated with adjuvant oral cyclophopsphamide. South Sweden Breast Cancer Group, trial SBII:I
(
- Contribution to journal › Published meeting abstract
-
Mark
The Scandinavian Sarcoma Group Summary of the first 30 years
(
- Contribution to journal › Article
-
Mark
The Scandinavian Sarcoma Group Register 1986-2008
(
- Contribution to journal › Article
-
Mark
Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
(
- Contribution to journal › Article
-
Mark
The European postmarketing adult Osteosarcoma Surveillance Study: characteristics of patients A preliminary report
(
- Contribution to journal › Article